NCT01004939View on ClinicalTrials.gov

Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
ThromboembolismVenous Thromboembolism
Interventions
DRUG

fondaparinux

fondaparinux

Trial Locations (7)

13353

GSK Investigational Site, Berlin

47051

GSK Investigational Site, Duisburg

48143

GSK Investigational Site, Münster

53115

GSK Investigational Site, Bonn

60590

GSK Investigational Site, Frankfurt am Main

68167

GSK Investigational Site, Mannheim

04289

GSK Investigational Site, Leipzig

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01004939 - Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism | Biotech Hunter | Biotech Hunter